Sarepta Therapeutics Vs. Regenxbio Industry Stock Comparison

Sell

38

SRPT
Sarepta Therapeutics

Last Price:

128.96

Seasonality Move:

11.13%

Sell

30

RGNX
Regenxbio

Last Price:

8.98

Seasonality Move:

-0.3%

Sell

38

Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

The current Sarepta Therapeutics [SRPT] share price is $130.19. The Score for SRPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

30

Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

The current Regenxbio [RGNX] share price is $9.05. The Score for RGNX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
RGNX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

The Sarepta Therapeutics share price today is $130.19
The current trend is moderately bullish and SRPT is experiencing slight selling pressure.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

The Regenxbio share price today is $9.05
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing slight selling pressure.

SRPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.05	Buy
Relative Strength Index (14 RSI):	58.34	Buy
Chaikin Money Flow:	-9031	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(120.84 - 128.84)	Buy
Bollinger Bands (100):	(123 - 147.2)	Sell

RGNX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.45	Sell
Relative Strength Index (14 RSI):	35.72	Sell
Chaikin Money Flow:	-175932	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(9.38 - 10.62)	Sell
Bollinger Bands (100):	(10.44 - 13.12)	Sell

SRPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	129.53	Buy
20-day SMA:	124.83	Buy
50-day SMA:	128.74	Buy
200-day SMA:	130.35	Sell
8-day EMA:	129.2	Buy
20-day EMA:	127.16	Buy
50-day EMA:	128.69	Buy
200-day EMA:	127.96	Buy

RGNX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	9.77	Sell
20-day SMA:	9.81	Sell
50-day SMA:	11.01	Sell
200-day SMA:	14.57	Sell
8-day EMA:	9.58	Sell
20-day EMA:	10	Sell
50-day EMA:	10.85	Sell
200-day EMA:	13.84	Sell

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

Analysts estimate an earnings increase this quarter of $2.72 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.19 per share, and an increase next year of $8.77 per share.

Regenxbio Earnings Growth & RGNX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.00 per share, and an increase next year of $3.77 per share.

Sarepta Therapeutics Technical Analysis

	Oct 15	Oct 16	Oct 18	Oct 21	Oct 22	Oct 23	Oct 24	Oct 25	Oct 28	Oct 29
	Oct
	15	16	18	21	22	23	24	25	28	29
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regenxbio Technical Analysis

	Oct 15	Oct 16	Oct 18	Oct 21	Oct 22	Oct 23	Oct 24	Oct 25	Oct 28	Oct 29
	Oct
	15	16	18	21	22	23	24	25	28	29
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):